<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02432781</url>
  </required_header>
  <id_info>
    <org_study_id>4-2015-0151</org_study_id>
    <nct_id>NCT02432781</nct_id>
  </id_info>
  <brief_title>Oral Carbohydrate in DM Patients Undergoing Total Knee Arthroplasty</brief_title>
  <official_title>Effect of Preoperative Oral Carbohydrates on Postoperative Nausea and Vomiting and Quality of Recovery in DM Patients Undergoing Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Severance Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to investigate the effects of carbohydrate-rich drink on
      postoperative nausea and vomiting in diabetic patients undergoing total knee arthroplasty.
      The secondary purpose is to investigate the effects of carbohydrate-rich drink on quality of
      recovery and inflammation in diabetic patients after total knee arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Carbohydrate-rich drink has been proved to neither delay gastric emptying nor affect gastric
      acidity and is therefore considered safe to use in elective surgical patients without risk
      factors for pulmonary aspiration. It reduced postoperative nausea and vomiting and improved
      sense of well-being after surgery. Moreover, carbohydrate-rich drink was not found to be
      affected by delayed gastric emptying in patients with uncomplicated type 2 diabetes.
      Therefore, carbohydrate drink may be safely administered 3 h before anesthesia without risk
      of hyperglycemia or aspiration.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 25, 2015</start_date>
  <completion_date type="Actual">December 14, 2017</completion_date>
  <primary_completion_date type="Actual">December 14, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of postoperative nausea and vomiting</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score of quality of recovery</measure>
    <time_frame>24 hours</time_frame>
    <description>Quality of recovery is determined by a 40-item quality-of-recovery questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of inflammation</measure>
    <time_frame>24 hours</time_frame>
    <description>Degree of inflammation is determined by white blood cell count, neutrophil count, and C-reactive protein</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Carbohydrate group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Carbohydrate-rich drink 400 mL 3 h before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10% dextrose solution mixed with insulin 16 unit 100 mL/h</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Carbohydrate-rich drink</intervention_name>
    <arm_group_label>Carbohydrate group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>10% dextrose solution mixed with insulin 16 unit 100 mL/h</intervention_name>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 DM patients undergoing elective total knee arthroplasty

        Exclusion Criteria:

          -  Contraindication to regional anesthesia

          -  Patients whose operation is scheduled to start after 9:00 am

          -  Dementia or cognitive dysfunction

          -  HbA1c &gt; 8%

          -  Gastroesophageal reflux disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Severance Hospital, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>April 23, 2015</study_first_submitted>
  <study_first_submitted_qc>April 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2015</study_first_posted>
  <last_update_submitted>September 4, 2018</last_update_submitted>
  <last_update_submitted_qc>September 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Severance Hospital</investigator_affiliation>
    <investigator_full_name>So Yeon Kim</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

